News-Medical.Net on MSN
Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...
HealthDay on MSN
Advanced prostate cancer drug combo found to be effective
A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...
Overall survival (OS) data, published simultaneously by the Journal of Clinical Oncology, 2 show the longest survival data ...
A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...
Recent studies reveal that triplet therapies significantly enhance progression-free survival in patients with ...
Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.
News-Medical.Net on MSN
New personalized therapy boosts tamoxifen effectiveness in breast cancer patients
Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback